Your Brain Is 60% Fat and Refuses to Take Cholesterol From Your Blood — So It Builds Its Own.
The molecule you were told to fear is so essential that your brain seals it behind a barrier and manufactures every molecule from scratch. This is the full picture of cholesterol — the history, the real scientific debate, the viral claims now spreading faster than the science, and the questions you are entitled to ask before you accept a lifelong prescription.
AJHerbs.com — The Full Picture“Your brain is the most cholesterol-rich organ in your body. It will not accept cholesterol from your bloodstream. It makes its own — and protects it for years.”
- The brain is 2% of body weight but holds ~25% of the body’s cholesterol. The blood-brain barrier blocks bloodstream cholesterol from entering. The brain synthesises essentially all of its own.
- A 2025 study (JACC Advances) followed 100 people with very high LDL (mean 254 mg/dL) for a year. Those without existing plaque developed no new plaque — and there was no correlation between LDL level and plaque.
- A Harvard researcher showed Oreo cookies lowered his LDL more than a high-intensity statin — a deliberate demonstration that for some people, an LDL number can be driven by metabolism, not by dietary “badness.”
- Statins carry an FDA-required warning for both increased diabetes risk and potential cognitive effects. Official regulatory acknowledgements — not fringe claims.
- For primary prevention, the number needed to treat to prevent one death can run into the hundreds over several years — while the relative-risk headline sounds far more dramatic.
Every one of these is true. None of them means “stop your medication.” What they mean is that the six-minute appointment that produced your prescription left out almost everything that matters. This article is the part that got left out.
This article is not telling anyone to stop taking medication. For people with existing cardiovascular disease, a prior heart attack, or familial hypercholesterolaemia, statins provide documented, potentially life-saving benefit. Stopping a statin after a cardiac event carries real, measured risk. This article exists to give you the complete picture — the history, the genuine scientific debate, the viral claims and what is true in them, and the questions you are entitled to bring to your doctor. It is education, not medical advice.
The Most Essential Molecule in Your Body
Your body produces cholesterol every single day because it cannot function without it. Not “tolerates” it. Cannot function without it. When a number comes back from a routine blood test, a prescription often follows — but the six minutes available rarely include what that molecule is actually doing every second you are alive.
Cholesterol regulates the fluidity and integrity of every cell membrane in your body — controlling what passes in and out of each of your ~37 trillion cells.
The brain holds ~25% of the body’s cholesterol. It is the primary structural component of the myelin sheaths that insulate every nerve fibre, and is essential for memory, learning, and serotonin function.
Testosterone, oestrogen, progesterone, cortisol, DHEA — every steroid hormone you make begins as cholesterol. No cholesterol means no hormones.
Your skin converts cholesterol into vitamin D on contact with sunlight. The starting material for the vitamin governing immunity and bone health is cholesterol itself.
Cholesterol is the raw material for bile acids — without which you cannot absorb dietary fats or fat-soluble vitamins A, D, E, and K.
Cholesterol concentrates at sites of tissue injury as part of the repair process. Its presence at a damaged site is often a response to the damage — not the cause of it.
Why the Brain Builds Its Own Cholesterol — and What That Tells You
Here is one of the most remarkable facts in human biology, and almost nobody is told it. The brain — the organ that depends on cholesterol more than any other — does not draw a single molecule of it from your blood. It cannot. The blood-brain barrier blocks the large cholesterol-carrying lipoproteins of the bloodstream from entering. So the brain manufactures all of its own, locally, from scratch.
The brain treats cholesterol as too important to outsource
Roughly 25% of all the cholesterol in your body sits in your brain, even though the brain is only 2% of your weight. Almost all of it is the product of local synthesis by glial cells called astrocytes and oligodendrocytes — not delivered from the diet or the bloodstream.
Up to 70% of brain cholesterol is locked into myelin — the insulating sheath wrapped around nerve fibres that lets electrical signals travel fast and accurately. Research has shown that a high cholesterol level is actually required for normal myelin membrane growth. In the brain, cholesterol’s relationship with health is almost the opposite of the simplified cardiovascular story.
And the brain guards this supply obsessively. Where cholesterol in your liver turns over in days, cholesterol in your brain can persist for months to years, recycled with minimal loss. When a system goes to this much trouble to build something itself and hold onto it for years, that is biology telling you the molecule is not a threat to be minimised. It is an asset to be protected.
Sources: Björkhem & Meaney, Arteriosclerosis Thrombosis Vascular Biology (brain cholesterol behind the barrier) · Saher et al., Nature Neuroscience (high cholesterol required for myelin growth) · AHA Scientific Statement on LDL-C lowering and the brain (2023).
This is where a viral claim now circulating — that statins “shred your brain’s cholesterol and cause Alzheimer’s” — gets the biology both right and badly wrong, in a way worth understanding precisely. We address it head-on in the myth-busters below. The accurate version of the brain story is more reassuring and more interesting than the frightening version: the brain is largely insulated from what happens to cholesterol in your blood, by design.
How a Number Became a Disease
High cholesterol produces no symptoms. You feel nothing. It became a “condition” to be medicated through a specific history — one worth knowing before you accept the framing.
Keys popularised the diet-heart hypothesis linking saturated fat and cholesterol to heart disease. Critics later noted that data from countries not fitting the pattern were not emphasised. The hypothesis hardened into policy faster than the evidence justified.
The 4S trial with simvastatin showed statins lowered cholesterol and reduced heart attacks and deaths in people with existing heart disease. For that population, the benefit was real and important — and it remains so today.
“Healthy” cholesterol thresholds were revised downward repeatedly. Each revision converted millions of previously healthy people into candidates for lifelong medication overnight — many for primary prevention, where the absolute benefit is far smaller.
The 2025 LMHR plaque study, the updated AHA PREVENT risk model (which would make up to 40% fewer people statin candidates), and a wave of viral metabolic-health arguments have reopened questions many assumed were settled. The science is more alive — and more contested — than the six-minute appointment suggests.
What That Number on Your Report Actually Is — and What It Is Not
After the pandemic, something good happened in Malaysia. People started taking their health seriously. Screenings at the Klinik Kesihatan, lipid panels at private labs, health-screening packages at the pharmacy. More people know their cholesterol number today than at any point in our history.
And into that new awareness, the likes-and-views hunters arrived. A number on a screen, a frightening caption, a thirty-second clip telling you that figure means you are heading for a heart attack — or, just as dangerously, that the number is a complete hoax and you should ignore it entirely. Both are wrong. Both are profitable. Neither is the truth.
So let us do something the thirty-second clip cannot. Let us tell you the truth about the number — not according to any single authority, but according to what the research actually shows.
First: do not panic. A single cholesterol number, on a single day, is not a diagnosis. It is not a verdict. It is one measurement, of one substance, taken at one moment, from a system of almost incomprehensible complexity. Whatever the number is — you have time. Cholesterol-driven arterial change happens over years and decades, not over the weekend between your test and your next appointment. Nothing about a number on a page requires a panicked decision.
The number is the end of the story — not the whole story
Here is what the clip will never tell you. The figure on your report is a single data point pulled from a process that took years to produce. Behind it sit thousands of contributing factors: the food across decades, the sleep, the stress hormones, the inflammation, the movement you did or did not do, the metabolic state of your liver, your genetics. The number is only a number because someone drew a circle around one substance and gave it a threshold.
This matters enormously, because it explains the single most confusing fact in this whole subject: the same number means completely different things in two different people. An LDL figure that signals real risk in a 60-year-old smoker with diabetes and existing plaque can be biologically unremarkable in a lean, active, metabolically healthy 35-year-old. The research is now explicit on this — a number stripped of its context is close to meaningless.
What the research says about reading the numbers
| What you see on the report | What it actually represents | What the research says about reading it |
|---|---|---|
| Total Cholesterol (TC) | Everything added together — the helpful and the harmful in one lump sum. | The least useful number on the page on its own. A “high” total can be driven by high protective HDL. Taken alone, it hides more than it reveals. |
| LDL Cholesterol | The carrier delivering cholesterol to your tissues — framed as “bad,” but essential. | Risk depends on whether it is oxidised and on particle size, neither of which a standard panel shows. The same LDL figure carries different meaning depending on the whole metabolic picture around it. |
| HDL Cholesterol | The carrier that returns cholesterol from tissues to the liver. | Generally protective — but trials of drugs that raise HDL artificially failed to reduce events. Higher is not automatically “more protection.” Context again. |
| Triglycerides (TG) | Fat circulating in the blood — strongly tied to diet and metabolic state. | One of the most responsive-to-lifestyle and arguably most informative numbers — yet often the least discussed in a six-minute appointment. |
| TG-to-HDL Ratio | Triglycerides divided by HDL — a window into metabolic health. | One of the most meaningful things a basic panel can tell you — a marker of the insulin resistance and metabolic dysfunction that drives oxidation. Rarely circled. Rarely explained. |
This is not a chart of “good” and “bad” numbers to memorise. It is a map of what each figure is actually measuring — so you can read your own report with understanding instead of fear.
The viral shorts get one thing very wrong: there is no universal target
This is where the loudest misinformation lives — in both directions. One clip says “LDL above this number = danger for everyone.” The next says “LDL targets are a scam, ignore them.” Both are selling certainty, and certainty is exactly what the research does not support.
What the evidence actually shows is that the level at which LDL matters is not a single line drawn across the whole population. It depends on the total cardiovascular risk of the individual — their age, blood pressure, blood sugar, smoking status, family history, and whether disease already exists. A person who has already had a heart event and a person who is young and metabolically healthy are not reading the same scale, even when their LDL numbers are identical. Any clip that hands you one universal cut-off — to fear it or to dismiss it — has already left out the one thing that determines what your number means.
The research supports the strongest case for lowering LDL aggressively here. This is where statins show their clearest, most documented benefit. The number genuinely matters most for this group.
Diabetes, high blood pressure, smoking, family history of early heart disease — the number is read in the context of the stack, not in isolation. The risk factors interact.
A lean, active, metabolically healthy person with an isolated high LDL is in genuinely contested territory — this is exactly the group the newest research is re-examining. The number alone is a weak predictor here.
One more truth: the fasting panic
Malaysians stress about fasting before the test — whether the kuih last night ruined the reading. Here is what the research found when it measured the same people fasting and non-fasting: the differences are small. Total cholesterol, LDL, and HDL barely move. Triglycerides rise modestly after eating, and settle within hours. For assessing your overall risk, a non-fasting sample is now considered acceptable in much of the world. The point is not that fasting is pointless — it is that one slightly-off reading is not the catastrophe a frightening caption makes it out to be. Single readings vary. Trends over time are what tell the truth.
So what do you actually do? Not panic. Not ignore it either. You do the thing the thirty-second clip can never sell, because there is no product in it: you get curious. You ask what is driving your number — the oxidation, the inflammation, the metabolic state underneath it. You look at the whole panel, not one line. You track the trend over months, not the scare of a single day. And you address the conditions upstream — the food, the movement, the sleep, the things that were driving the number long before it appeared on a page.
There is no single number that is the whole truth. And there is no single pill that resolves what thousands of small things, accumulated over years, produced. The number is not the enemy. It is the invitation to understand what your body has been trying to tell you.
The Relative Risk Headline vs. the Absolute Number
This is the single most important statistical concept your appointment almost certainly skipped — and it is now one of the most viral arguments online, for good reason.
When you read that a statin “cuts heart attack risk by 36%,” that is a relative risk reduction. It sounds enormous. But relative numbers hide the baseline. If your real risk drops from roughly 2 in 100 to roughly 1 in 100 over several years, that is the same “50% reduction” — while the absolute benefit is about 1 percentage point.
The dramatic-sounding headline number commonly cited for statins in eligible groups.
The actual percentage-point change in risk for many lower-risk people over several years.
Published NNT estimates: ~60 people treated 5 years to prevent one heart attack; ~268 to prevent one stroke.
Under the updated AHA PREVENT model, up to 40% fewer people would qualify for statins than under prior guidelines.
None of this means statins do not work. For secondary prevention — people who already have heart disease or have had an event — the absolute benefit is much larger and the case is strong. The point is that “36%” and “1 percentage point” can describe the very same study, and you are entitled to know which one applies to you before deciding.
Statins Block the Same Pathway That Produces CoQ10
One pathway. Two products. Block one, you reduce both.
Statins work by inhibiting HMG-CoA reductase — the rate-limiting enzyme of the mevalonate pathway. That is how they lower cholesterol production in the liver. But the same pathway also produces Coenzyme Q10 (ubiquinone) — a molecule essential for energy production in every mitochondrion in your body.
Block the top of the pathway and you reduce both products. This is the documented mechanism behind statin-associated muscle symptoms and fatigue: the muscle and heart are among the most energy-hungry tissues, and they depend on CoQ10. Many doctors who prescribe statins do not mention CoQ10 at all. Some cardiologists routinely recommend supplementation alongside.
This is a question worth raising directly — especially if you experience muscle aches, weakness, or unusual fatigue after starting a statin.
What Is Cholesterol Actually Doing When It Is High?
The most important distinction in this entire subject — and the one most consistently lost in the “LDL = bad” shorthand:
It is oxidised LDL — not LDL itself — that damages arteries
LDL is a delivery vehicle, carrying cholesterol to cells that need it. In a healthy, low-inflammation arterial environment, LDL does its job and is cleared. The problem begins when LDL particles become oxidised — damaged by free radicals in an environment of chronic inflammation and oxidative stress.
Oxidised LDL is what the immune system treats as a threat. It is what gets taken up by macrophages to form the foam cells that build arterial plaque. Native, un-oxidised LDL in an otherwise healthy person behaves very differently from oxidised LDL in an inflamed, sugar-stressed, smoke-exposed body.
This is why a person can have “high” LDL and clean arteries, while another can have “normal” LDL and significant disease. The number on the panel does not tell you the oxidation state — and oxidation is driven by inflammation, refined carbohydrate, smoking, and oxidative stress far more than by the LDL number itself.
This is consistent with the 2025 finding that high LDL without existing plaque did not generate new plaque, and with the long-running scientific argument over cholesterol versus inflammation as the driver of chronic arterial disease.
“If half of heart attack patients have normal cholesterol, and a person can carry very high LDL with clean arteries — then the number on the panel was never the whole story. The question is what is driving oxidation and inflammation in your body.”
The Viral Claims — Each One, Honestly
Social media has reopened the cholesterol debate — and it has produced both genuine insight and dangerous misinformation, often in the same post. Here is each major claim now circulating, with an honest verdict. We cut both ways: against the establishment oversimplifications and against the viral overcorrections.
“Statins shred your brain’s cholesterol and cause Alzheimer’s — it’s medical malpractice.”
The kernel of truth: The brain is cholesterol-dependent, myelin is cholesterol-rich, and statins do carry an FDA cognitive-effects warning. Those facts are real.
Where it goes wrong: The claim that statins “steal 75% of your brain’s cholesterol” is false. Brain cholesterol is made locally behind the blood-brain barrier and is largely independent of the liver cholesterol that statins act on. Most statins barely cross the barrier; the brain’s own synthesis rate is under 2% of the liver’s, and brain cholesterol is recycled for years. The “myelin is 100% cholesterol” figure is invented — myelin is roughly 70–80% lipid, of which cholesterol is one major part.
The honest verdict: The statin–dementia link is genuinely contested — studies show harmful, neutral, and even protective effects, with recent evidence not strongly supporting a causal link. “Physician-caused disease” and “malpractice” are not supported. The strongest brain–cholesterol–Alzheimer’s connection in the literature is genetic (the APOE4 gene), not statin-driven. Cognitive symptoms on statins are worth discussing with your doctor — lipophilic statins differ from hydrophilic ones — but the apocalyptic version is wrong.
“Oreos lowered LDL more than statins — so cholesterol numbers are meaningless.”
What actually happened: A Harvard researcher (Nick Norwitz) on a ketogenic diet ate Oreos daily for two weeks and his LDL dropped more than it did on a high-intensity statin. The experiment was real and deliberately provocative.
What it actually shows: In a specific phenotype — the Lean Mass Hyper-Responder (LMHR): lean, metabolically healthy, low-carb — LDL can rise on a ketogenic diet for energy-metabolism reasons (the lipid energy model), and adding carbohydrate back drops it fast. It illustrates that an LDL number can be driven by metabolic context, not dietary “badness.”
What it does NOT show: It is a single person (n=1), not evidence that LDL is meaningless for everyone, and not a recommendation to eat Oreos. Norwitz himself says it lacked rigour and is not medical advice. The lesson is narrow but real: context determines what an LDL number means.
“High LDL is harmless — the keto/carnivore plaque study proves cholesterol doesn’t cause heart disease.”
The real study: The 2025 LMHR study (JACC Advances) followed 100 lean, low-carb people with very high LDL (mean 254 mg/dL) for a year using CT angiography. It found no increase in plaque versus matched controls, and no correlation between LDL level and plaque in this specific group.
What it legitimately challenges: The idea that an LDL number alone, stripped of metabolic context, predicts plaque in a lean and metabolically healthy person. That is a real and important challenge to “LDL = bad, full stop.”
Where the overcorrection lies: One year is short for atherosclerosis, the population was specifically selected (lean, healthy, low triglycerides, high HDL), and it does not transfer to someone with diabetes, hypertension, smoking, or existing plaque. “Cholesterol doesn’t cause heart disease” is not what this study shows. “LDL in isolation, in a metabolically healthy person, is a weak predictor” is.
“High cholesterol causes heart disease.”
High LDL is associated with cardiovascular risk in specific populations — particularly those with existing disease or multiple risk factors. But roughly half of heart attack patients have normal or low cholesterol. The accurate statement: oxidised LDL in an inflamed arterial environment contributes to plaque. LDL alone in an otherwise healthy person is a far weaker predictor than the “causes heart disease” shorthand implies.
“Eating cholesterol raises your blood cholesterol.”
The 2015 US Dietary Guidelines removed the warning against dietary cholesterol, acknowledging it has no significant effect on blood cholesterol in most people. The liver compensates automatically — eat more, produce less. Decades of advice to avoid eggs for heart health were not supported by the evidence even when issued. Blood cholesterol is governed mainly by liver function, genetics, and metabolic health.
“Saturated fat causes heart disease.”
A 2010 meta-analysis of nearly 350,000 people found no significant association between saturated fat intake and cardiovascular disease. The blanket directive was built largely on selectively presented mid-century data. That said, this remains genuinely debated — the type of fat, the food it comes in, what it replaces in the diet, and individual metabolic variation all matter. “Saturated fat is poison” and “saturated fat is irrelevant” are both overstatements.
“Statins are dangerous poison and everyone should avoid them.”
For people with existing cardiovascular disease, statins measurably reduce heart attack and stroke. This is real. In Australia, a TV programme about statin dangers caused prescriptions to drop sharply — researchers attributed thousands of avoidable cardiac events to people stopping. The legitimate debate is about who should be prescribed statins — especially in primary prevention — not whether they work for those who genuinely need them. Telling everyone to avoid them is as wrong as prescribing them to everyone.
“HDL is always good. LDL is always bad.”
LDL and HDL are lipoprotein carriers, not cholesterol itself. Recent trials of drugs that raise HDL found no consistent preventive benefit. Small, dense LDL particles are more dangerous than large, buoyant ones — but a standard panel does not distinguish them. The triglyceride-to-HDL ratio — rarely discussed in a six-minute appointment — is one of the most meaningful numbers a basic lipid panel can give you about metabolic health.
“A high LDL number always means you need medication.”
A high LDL number in isolation — in an active, metabolically healthy person with good HDL, low triglycerides, low CRP, no existing plaque, no diabetes, no hypertension, and no early family history of cardiovascular disease — is a completely different situation from high LDL stacked on multiple risk factors. The updated AHA PREVENT model would remove up to 40% of current statin candidates. Lifestyle change produces real lipid improvement for many people with no drug at all. The number is the start of a conversation, not the end of one.
The Malaysian Kitchen Already Holds Part of the Answer
These are not treatments and not statin replacements. They are foods with documented effects on the conditions under which cholesterol behaves appropriately — oxidation, inflammation, and metabolic health — used daily, as the traditional kitchen always used them.
Serai (lemongrass): documented cholesterol-lowering and anti-inflammatory activity; contains citral, studied for its effect on lipid metabolism.
Halba (fenugreek): soluble fibre and saponins with documented effects on LDL and blood sugar — one of the most evidence-supported culinary herbs for lipids.
Kunyit (turmeric): curcumin acts on the inflammatory and oxidative environment that converts harmless LDL into the oxidised form that builds plaque.
Halia (ginger): documented effects on lipids and on the inflammatory signalling underlying arterial disease — backed by a large body of randomised trials.
The traditional Malay diet did not target a cholesterol number. It maintained the metabolic conditions in which the number rarely became a problem. That is the upstream approach — and it is exactly what the masakan delivered daily, long before anyone owned a lipid panel.
Questions Worth Bringing to Your Doctor
You are entitled to the full conversation. These are the questions that open it.
- “Is my prescription for primary or secondary prevention? What is my absolute risk reduction — in percentage points, not relative percent — and my number needed to treat?”
- “What is my triglyceride-to-HDL ratio, and my CRP (inflammation marker)? Do we know my LDL particle size, or just the total number?”
- “Would I qualify for a statin under the updated AHA PREVENT risk model, or only under the older guidelines?”
- “Should I be supplementing CoQ10, given that statins inhibit the pathway that produces it — especially if I develop muscle aches or fatigue?”
- “If I experience memory or concentration changes, would switching from a lipophilic to a hydrophilic statin be worth considering?”
- “Could we set a defined window to try lifestyle changes first — refined-carbohydrate reduction, seed-oil swaps, exercise, sleep — and re-test before committing to lifelong medication?”
This article is not telling anyone to stop taking medication. That is a decision between you and your doctor, based on your full history and risk profile. Stopping a statin after a cardiac event, or with established cardiovascular disease, carries documented risk.
What this article gives you is the full picture the six-minute appointment cannot contain: the history, the genuine scientific debate, the viral claims and exactly what is true and false in each, the documented side effects and their mechanisms, the questions you are entitled to ask, and the upstream lifestyle approach that addresses oxidation and inflammation rather than a downstream number.
Read widely. Think independently. Bring the complete set of questions to your doctor. You are entitled to that conversation.
This article is for educational purposes only and is not medical advice. If you have existing cardiovascular disease, a prior heart attack, or familial hypercholesterolaemia, statins may be providing documented, potentially life-saving benefit that outweighs the considerations discussed here. Do not stop prescribed medication without consulting your doctor. This content has not been evaluated by KKM (Malaysian Ministry of Health) and is not intended to diagnose, treat, cure, or prevent any disease.
References & Sources ↓
- Soto-Mota A, Norwitz NG, Feldman D, Budoff M, et al. Coronary artery plaque in Lean Mass Hyper-Responders on ketogenic diets. JACC Advances (2025) — 1-year CT angiography data.
- Norwitz NG, Cromwell WC. Oreo Cookie Treatment vs High-Intensity Statin in a Lean Mass Hyper-Responder (2024).
- Norwitz NG, Soto-Mota A, Feldman D, Parpos S, Budoff M. Case Report: LMHR Phenotype. Frontiers in Endocrinology 13:830325 (2022).
- Bjorkhem I, Meaney S. Brain Cholesterol: Long Secret Life Behind a Barrier. Arteriosclerosis, Thrombosis, and Vascular Biology.
- Saher G et al. High cholesterol level is essential for myelin membrane growth. Nature Neuroscience 8(4):468-475 (2005).
- American Heart Association Scientific Statement. Aggressive LDL-C Lowering and the Brain: Dementia and Hemorrhagic Stroke Risk (2023).
- Narrative review: Do Statins Affect Cognitive Health? PMC11550230 (2024) — mixed/neutral cognitive findings.
- FDA statin label changes (2012): diabetes risk and cognitive-effect warnings.
- AAFP / NNT analyses of statins in primary prevention; STAT News NNT summary (heart attack ~60, stroke ~268).
- Panchal SK, Brown L. Cholesterol versus Inflammation as Cause of Chronic Diseases. Nutrients 11(10):2332 (2019).
- AHA PREVENT risk model (2023–2024) and projected statin-eligibility changes.
- 2015 US Dietary Guidelines Advisory Committee — removal of dietary cholesterol restriction.
- Note: this article reports a live scientific debate. Where evidence is contested or preliminary, it is labelled as such.